TaƱajoras, Mark Gede L.
HRN: 23-81-59 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/02/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/02/2023
10/08/2023
IVTT
250 Mg
Q8
Acute Appendicitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes